Tidal Investments’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Tidal Investments’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-274,400	Closed	-$15.6M	–	2117
2025 Q2	$15.6M	Buy	+274,400	New	+$14.6M	0.09%	250
2024 Q4	–	Sell	-70,000	Closed	-$9.01M	–	1931
2024 Q3	$9.01M	Buy	+70,000	New	+$9.13M	0.1%	206
2024 Q2	–	Sell	-14,000	Closed	-$1.86M	–	1880
2024 Q1	$1.86M	Buy	+14,000	New	+$1.83M	0.03%	576

Other funds holding LABU

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

Tidal Investments's LABU Position: Q3 2025 in Review

Tidal Investments sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2025, closing a stake of 274,400 shares — an estimated $15.6M sold.

Tidal Investments first reported a position in LABU in Q1 2024 and held it in 3 quarters. The position peaked at $15.6M in Q2 2025. 40 funds tracked by Wall St. Rank hold LABU as of Q3 2025.

Tidal Investments reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2025 after selling out during the quarter.
Tidal Investments sold 274,400 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2025, an estimated $15.6M.
Tidal Investments first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2024 and held it in 3 quarters.
Tidal Investments's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $15.6M in Q2 2025.
40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2025.

Based on Tidal Investments's 13F filing for Q3 2025, filed 14 Nov 2025.